[Federal Register Volume 70, Number 250 (Friday, December 30, 2005)]
[Notices]
[Pages 77399-77400]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-8100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH) of
the Centers for Disease Control and Prevention (CDC) Announces the
Following Meeting and Opening of the Public Comment Period
Name: The Draft Document: NIOSH Current Intelligence
Bulletin: Evaluation of Health Hazard and Recommendations for
Occupational Exposure to Titanium Dioxide.
Meeting Date and Time: February 27, 2006, 9 a.m.-4 p.m.
Place: Robert A. Taft Laboratories, Taft Auditorium, NIOSH, CDC,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
Purpose: To explain and discuss the scientific basis for the draft
document, ``NIOSH Current Intelligence Bulletin: Evaluation of Health
Hazard and Recommendations for Occupational Exposure to Titanium
Dioxide,'' current research on titanium dioxide, and information on
occupational exposure to titanium dioxide. Special emphasis will be
placed on discussion of the following:
(1) What animal and human data best describe the health concerns
from exposure to titanium dioxide; (2) What strategies are being used
to control occupational exposure to titanium dioxide (e.g., engineering
controls, work practices, personal protective equipment); (3) In which
workplaces and occupations can exposure to titanium dioxide occur; (4)
What challenges exist in measuring workplace exposures to titanium
dioxide; (5) What are areas for future collaborative efforts (e.g.,
research, communication, development of exposure measurement and
control strategies)?
The public is invited to attend and will have the opportunity to
provide comments.
NIOSH seeks to obtain materials, including published and
unpublished reports and research findings, to evaluate the possible
health risks of occupational exposure to titanium dioxide (including
particle size-specific information). Examples of requested information
include, but are not to be limited to, the following: (1)
Identification of industries or occupations in which exposures to
titanium dioxide may occur; (2) Trends in the production and use of
titanium dioxide; (3) Description of work tasks and scenarios with a
potential for exposure to titanium dioxide; (4) Current and historical
exposure measurement data in various types of industries and jobs; (5)
Case reports or other health information demonstrating health effects
in workers exposed to titanium dioxide; (6) Reports of experimental in
vivo and in vitro studies that provide evidence of a dose-relationship
between the particle size of a substance and its biological activity;
(7) Reports of experimental inhalation studies with rodents
demonstrating a relationship between the particle size or surface area
of a substance and lung inflammation, fibrosis, and biochemical
mediators; (8) Description of work practices and engineering controls
used to reduce or prevent workplace exposure to titanium dioxide. (9)
[[Page 77400]]
Educational materials for worker safety and training on the safe
handling of titanium dioxide; (10) Data pertaining to the feasibility
of establishing particle size-specific RELs for titanium dioxide.
NIOSH will use this information to assess the scientific basis for
the draft worker health recommendations contained in the draft Current
Intelligence Bulletin and determine the need for revision to those
draft recommendations for reducing occupational exposure to titanium
dioxide.
Status: The forum will include scientists and representatives from
various government agencies, industry, labor, and other stakeholders,
and is open to the public, limited only by the space available. The
meeting room accommodates 80 people. Due to limited space, notification
of intent to attend the meeting must be made to Diane Miller no later
than February 14, 2006. Ms. Miller can be reached by telephone at 513/
533-8450 or by e-mail at [email protected]. Requests to attend the
meeting will be accommodated on a first-come basis.
Non-U.S. Citizens: Because of CDC Security Regulations, any non-
U.S. citizen wishing to attend this meeting must provide the following
information in writing to Diane Miller at the address below no later
than February 14, 2006: (1) Visitor's full name; (2) Gender; (3) Date
of Birth; (4) Place of birth (city, province, state, country); (5)
Citizenship; (6) Passport number; (7) Date of passport issue; (8) Date
of passport expiration; (9) Type of Visa; (10) Visitor's organization;
(11) Organization address; (12) Organization telephone number; (13)
Visitor's position/title within the organization.
This information will be transmitted to the CDC Security Office for
approval. Visitors will be notified as soon as approval has been
obtained.
A copy of the draft Current Intelligence Bulletin Evaluation of
Health Hazard and Recommendations for Occupational Exposure to Titanium
Dioxide can be obtained from the Internet at http://www.cdc.gov/niosh/docs/preprint/tio2 or a hard copy may be requested from the Docket
Officer, Diane Miller (contact information below).
Addresses: Comments should be submitted to the NIOSH Docket Office,
ATTN: Diane Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway,
M/S C-34, Cincinnati, Ohio 45226, telephone 513/533-8450, fax 513/533-
8285.
Comments may also be submitted directly through the Web site
(http://www.cdc.gov/niosh/docs/preprint/tio2) or by e-mail to
[email protected]. E-mail attachments should be formatted in
Microsoft Word. Comments should be submitted to NIOSH no later than
March 31, 2006, and should reference docket number NIOSH-033 in the
subject heading.
Oral comments made at the public meeting must also be submitted to
the docket in writing in order to be considered by the Agency.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, Room 111, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Contact Persons For Technical Information: Christine Sofge 513/533-
8439 or Faye Rice 513/533-8335, M/S C-15, Robert A. Taft Laboratories,
4676 Columbia Parkway, Cincinnati, Ohio 45226.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: December 22, 2005.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E5-8100 Filed 12-29-05; 8:45 am]
BILLING CODE 4163-18-P